Premium
Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain
Author(s) -
Zhong J,
Iqbal K,
Grundke-Iqbal I
Publication year - 1999
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(99)00715-2
Subject(s) - sh sy5y , hyperphosphorylation , tau protein , microtubule , tauopathy , microtubule associated protein , microbiology and biotechnology , alzheimer's disease , neuroscience , biology , cell culture , chemistry , neurodegeneration , phosphorylation , neuroblastoma , disease , medicine , genetics
Unlike normal tau, abnormally hyperphosphorylated tau (AD P‐tau) from Alzheimer disease (AD) does not promote but instead inhibits microtubule assembly and disrupts already formed microtubules. Tau in the human neuroblastoma cell line SH‐SY5Y is hyperphosphorylated at several of the same sites as AD P‐tau, and accumulates in the cell body without any association to the cellular microtubule network. The aim of the present study was to elucidate why the SY5Y tau does not affect the viability of the cells. We found that, like AD P‐tau, SY5Y tau because of hyperphosphorylation does not bind to microtubules and inhibits the tau‐promoted assembly of microtubules. However, the tau/HMW MAP ratio is about 10 times less in SY5Y cells than in AD brain. These findings suggest that the hyperphosphorylated tau from SY5Y cells has similar biological characteristics as AD P‐tau from AD brain, but is not lethal to the SY5Y cells because of its low tau/HMW MAP ratio.